As of 2024-12-12, the Relative Valuation of Initiator Pharma A/S (INIT.ST) is (7.91) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 7.10 SEK, the upside of Initiator Pharma A/S based on Relative Valuation is -211.5%.
The range of the Relative Valuation is (7.00) - (7.29) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 18.6x | 17.7x |
| Forward P/E multiples | 11.4x - 14.7x | 14.3x |
| Fair Price | (7.00) - (7.29) | (7.91) |
| Upside | -198.6% - -202.7% | -211.5% |
| Date | P/E |
| 2024-12-06 | -158.07 |
| 2024-12-05 | -160.28 |
| 2024-12-04 | -162.49 |
| 2024-12-03 | -163.60 |
| 2024-12-02 | -158.07 |
| 2024-11-29 | -164.70 |
| 2024-11-28 | -159.18 |
| 2024-11-27 | -154.76 |
| 2024-11-26 | -148.12 |
| 2024-11-25 | -148.12 |
| 2024-11-22 | -142.60 |
| 2024-11-21 | -147.02 |
| 2024-11-20 | -150.33 |
| 2024-11-19 | -147.02 |
| 2024-11-18 | -151.44 |
| 2024-11-15 | -149.23 |
| 2024-11-14 | -153.65 |
| 2024-11-13 | -156.97 |
| 2024-11-12 | -152.54 |
| 2024-11-11 | -144.81 |
| 2024-11-08 | -156.97 |
| 2024-11-07 | -154.76 |
| 2024-11-06 | -149.23 |
| 2024-11-05 | -156.97 |
| 2024-11-04 | -154.76 |
| 2024-11-01 | -159.18 |
| 2024-10-31 | -159.18 |
| 2024-10-30 | -159.18 |
| 2024-10-29 | -156.97 |
| 2024-10-28 | -159.18 |
| 2024-10-25 | -162.49 |
| 2024-10-24 | -156.97 |
| 2024-10-23 | -155.86 |
| 2024-10-22 | -163.60 |
| 2024-10-21 | -158.07 |
| 2024-10-18 | -156.97 |
| 2024-10-17 | -159.18 |
| 2024-10-16 | -160.28 |
| 2024-10-15 | -162.49 |
| 2024-10-14 | -159.18 |
| 2024-10-11 | -159.18 |
| 2024-10-10 | -155.86 |
| 2024-10-09 | -159.18 |
| 2024-10-08 | -155.86 |
| 2024-10-07 | -161.39 |
| 2024-10-04 | -170.23 |
| 2024-10-03 | -165.81 |
| 2024-10-02 | -164.70 |
| 2024-10-01 | -166.91 |
| 2024-09-30 | -163.60 |